Davis Asset Management boosted its position by approximately $53 million in this provider of real estate-related services.

If you are wondering whether Travere Therapeutics is still good value after its big rebound, you are not alone. This stock has quickly moved from recovery story to serious contender on many watchlists ...

You face some pretty steep odds to win the Powerball jackpot, like a 1 in 292.2 million chance. So is there any way to get edge? Start the day smarter. Get all the news you need in your ...

After a weak first half, the drug and biotech sector regained momentum in the latter part of 2025, setting the stage for a ...